Balaxi Pharmaceuticals Limited (NSE: BALAXI.NS) AI-Powered Stock Analysis
See how Balaxi Pharmaceuticals Limited scores across key metrics like financial growth, valuation, and market position on the NSE, using AI-driven evaluation.
BALAXI.NS●NSE
HealthcareMedical - Distribution
₹22.40
₹0.10(0.45%)
Indian Market opens in 21h 51m
Balaxi Pharmaceuticals Limited (NSE: BALAXI.NS) AI-Powered Stock Analysis
See how Balaxi Pharmaceuticals Limited scores across key metrics like financial growth, valuation, and market position on the NSE, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerBalaxi Pharmaceuticals Limited (NSE: BALAXI.NS) Stock Overall Grade
Balaxi Pharmaceuticals Limited's grade for its NSE listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Balaxi Pharmaceuticals Limited's overall NSE stock rating.
Forecast
C+Score
57/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
51/100Key Ratios
BScore
64/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
C+Score
50/100Balaxi Pharmaceuticals Limited (NSE: BALAXI.NS) AI-Powered Stock Analysis
On the NSE, BALAXI.NS demonstrates Good performance with an overall Forecast Score of 57/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (51/100, C+) highlight its stability, while Key Ratios (64/100, B) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), the NSE-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.(NSE: BALAXI.NS) Component Analysis Explained
Understand the key factors behind each Balaxi Pharmaceuticals Limited (NSE: BALAXI.NS) stock grade, including financials, comparisons, and forecasts.